GW Pharmaceuticals

Latest stories

2d
FOX Business
Don't Fall Over, but Medical Marijuana Just Scored a Big Victory on Capitol Hillcause. In one corner we have patients and some physicians who see discernable t
Don't Fall Over, but Medical Marijuana Just Scored a Big Victory on Capitol Hill
FOX Business / Posted 2 days ago
cause. In one corner we have patients and some physicians who see discernable treatment benefits from medical marijuana. GW Pharmaceuticals , a predominantly clinical-stage drug developer that's focused on creating medicines derived from... Read more
2d
FOX Business
Don't Fall Over, but Medical Marijuana Just Scored a Big Victory on Capitol Hillcause. In one corner we have patients and some physicians who see discernable t
Don't Fall Over, but Medical Marijuana Just Scored a Big Victory on Capitol Hill
FOX Business / Posted 2 days ago
cause. In one corner we have patients and some physicians who see discernable treatment benefits from medical marijuana. GW Pharmaceuticals , a predominantly clinical-stage drug developer that's focused on creating medicines derived from... Read more
4d
CNBC
My speculative play on potstocks, it's under $300 million [market cap] but I know that things are doing r
My speculative play on pot
CNBC / Posted 4 days ago
stocks, it's under $300 million [market cap] but I know that things are doing really well there. I would hold on." GW Pharmaceuticals: "GW Pharma is incredibly speculative. This is a play on the ultimate legalization of pure marijuana as a... Read more
6d
FOX Business
This Marijuana Stock Takes a Step ForwardImage source: GW Pharmaceuticals. After reporting that it has completed a phas
This Marijuana Stock Takes a Step Forward
FOX Business / Posted 6 days ago
Image source: GW Pharmaceuticals. After reporting that it has completed a phase 1/2 dosing study of its synthesized marijuana cannabidiol, or CBD, shares in Insys Therapeutics climbed 6.2% today. Today's news positions the company to play catch-up... Read more
6d
FOX Business
This Marijuana Stock Takes a Step ForwardImage source: GW Pharmaceuticals. Continue Reading Below After reporting that
This Marijuana Stock Takes a Step Forward
FOX Business / Posted 6 days ago
Image source: GW Pharmaceuticals. Continue Reading Below After reporting that it has completed a phase 1/2 dosing study of its synthesized marijuana cannabidiol, or CBD, shares in Insys Therapeutics climbed 6.2% today. Today's news positions the... Read more
7d
Market Watch
Nasdaq rejects cannabis company’s listing applicationago businesses like ours were being raided and shuttered on a weekly basis.” A
Nasdaq rejects cannabis company’s listing application
Market Watch / Posted 7 days ago
ago businesses like ours were being raided and shuttered on a weekly basis.” Additionally, biotechnology companies like GW Pharmaceuticals GWPH, +2.24% that perform medical research with cannabis are allowed to list because of their... Read more
9d
FOX Business
9 Fast Facts About Marijuana, Including 1 Telling Statisticto see marijuana legalized for medicinal use nationwide. It's not hard to under
9 Fast Facts About Marijuana, Including 1 Telling Statistic
FOX Business / Posted 9 days ago
to see marijuana legalized for medicinal use nationwide. It's not hard to understand why, either, with companies like GW Pharmaceuticals showcasing the many uses of cannabinoids in early- and mid-stage clinical trials. For instance, GW... Read more
9d
FOX Business
9 Fast Facts About Marijuana, Including 1 Telling Statisticto see marijuana legalized for medicinal use nationwide. It's not hard to under
9 Fast Facts About Marijuana, Including 1 Telling Statistic
FOX Business / Posted 9 days ago
to see marijuana legalized for medicinal use nationwide. It's not hard to understand why, either, with companies like GW Pharmaceuticals showcasing the many uses of cannabinoids in early- and mid-stage clinical trials. For instance, GW... Read more
11d
FOX Business
3 Charts Show Why This Marijuana Stock Is Risky BusinessImage source: GW Pharmaceuticals PLC. GW Pharmaceuticals plc is knee-deep in d
3 Charts Show Why This Marijuana Stock Is Risky Business
FOX Business / Posted 11 days ago
Image source: GW Pharmaceuticals PLC. GW Pharmaceuticals plc is knee-deep in developing medicine that's derived from marijuana. It's been researching the medical benefits of marijuana cannabinoids since the 1990s, and it already has one marijuana... Read more
11d
FOX Business
3 Charts Show Why This Marijuana Stock Is Risky BusinessImage source: GW Pharmaceuticals PLC. Continue Reading Below GW Pharmaceutica
3 Charts Show Why This Marijuana Stock Is Risky Business
FOX Business / Posted 11 days ago
Image source: GW Pharmaceuticals PLC. Continue Reading Below GW Pharmaceuticals plc is knee-deep in developing medicine that's derived from marijuana. It's been researching the medical benefits of marijuana cannabinoids since the 1990s, and it... Read more
17d
FOX Business
What You Need To Know About Investing In Marijuana Stocksleft with many marijuana stocks to consider. Among those marijuana companies th
What You Need To Know About Investing In Marijuana Stocks
FOX Business / Posted 17 days ago
left with many marijuana stocks to consider. Among those marijuana companies that investors might want on their radar are GW Pharmaceuticals and Insys Therapeutics , two companies that are developing marijuana-based medicines. Both GW Pharma and... Read more
17d
FOX Business
What You Need To Know About Investing In Marijuana Stocksleft with many marijuana stocks to consider. Among those marijuana companies th
What You Need To Know About Investing In Marijuana Stocks
FOX Business / Posted 17 days ago
left with many marijuana stocks to consider. Among those marijuana companies that investors might want on their radar are GW Pharmaceuticals and Insys Therapeutics , two companies that are developing marijuana-based medicines. Both GW Pharma and... Read more
19d
FOX News
Medical pot activists fear epilepsy drug could undercut themwhich he said is effective, consistent and doesn't get users high. About two y
Medical pot activists fear epilepsy drug could undercut them
FOX News / Posted 19 days ago
which he said is effective, consistent and doesn't get users high. About two years ago, Patel persuaded London-based GW Pharmaceuticals to give him enough of the medicine for a single patient, and his hospital's study was born. Last month,... Read more
19d
FOX News
GW Pharma's cannabis drug gets orphan drug statusThe U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuticals Plc'
GW Pharma's cannabis drug gets orphan drug status
FOX News / Posted 19 days ago
The U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuticals Plc's experimental cannabis-derived epilepsy drug "orphan" status for a third group of patients affected by a rare form of the disease. GW said on Thursday that its drug,... Read more
21d
The Advocate
Louisiana Sheriffs' Association leaders: Balance needed on medical marijuanaof cannabidiol) revealed positive outcomes for children suffering from two epil
Louisiana Sheriffs' Association leaders: Balance needed on medical marijuana
The Advocate / Posted 21 days ago
of cannabidiol) revealed positive outcomes for children suffering from two epileptic seizure disorders. The manufacturer, GW Pharmaceuticals, is expected to file for a new drug application this year with the FDA. One of the major hurdles patients... Read more
22d
The Advocate
Guest column: Balance needed on medical marijuanaof cannabidiol) revealed positive outcomes for children suffering from two epil
Guest column: Balance needed on medical marijuana
The Advocate / Posted 22 days ago
of cannabidiol) revealed positive outcomes for children suffering from two epileptic seizure disorders. The manufacturer, GW Pharmaceuticals, is expected to file for a new drug application this year with the FDA. One of the major hurdles patients... Read more
24d
FOX Business
The Controversial Drug That Could Be Better at Controlling Seizures in Epilepsy Patients Than MarijuSOURCE: GW PHARMACEUTICALS, PLC. Earlier this week, clinical-stage drug develo
The Controversial Drug That Could Be Better at Controlling Seizures in Epilepsy Patients Than Mariju
FOX Business / Posted 24 days ago
SOURCE: GW PHARMACEUTICALS, PLC. Earlier this week, clinical-stage drug developer Zogenix updated results from studies evaluating the use of low-dose fenfluramine in patients with a rare form of epilepsy called Dravet syndrome. The company's results... Read more
3 related stories
24d
FOX Business
The Controversial Drug That Could Be Better at Controlling Seizures in Epilepsy Patients Than MarijuSOURCE: GW PHARMACEUTICALS, PLC. Continue Reading Below Earlier this week, cl
The Controversial Drug That Could Be Better at Controlling Seizures in Epilepsy Patients Than Mariju
FOX Business / Posted 24 days ago
SOURCE: GW PHARMACEUTICALS, PLC. Continue Reading Below Earlier this week, clinical-stage drug developer Zogenix updated results from studies evaluating the use of low-dose fenfluramine in patients with a rare form of epilepsy called Dravet... Read more
3 related stories
24d
FOX Business
Marijuana Gains Global Support With Approvals On The Horizon In Germany and Canadamarinol, a drug derived from the cannabinoid THC, and MS patients who suffer fr
Marijuana Gains Global Support With Approvals On The Horizon In Germany and Canada
FOX Business / Posted 24 days ago
marinol, a drug derived from the cannabinoid THC, and MS patients who suffer from muscle spasticity can be prescribed GW Pharmaceuticals' Sativex, a spray formulation of THC. Soon, many more patients who suffer from a variety of otherwise... Read more
24d
FOX Business
Marijuana Gains Global Support With Approvals On The Horizon In Germany and Canadamarinol, a drug derived from the cannabinoid THC, and MS patients who suffer fr
Marijuana Gains Global Support With Approvals On The Horizon In Germany and Canada
FOX Business / Posted 24 days ago
marinol, a drug derived from the cannabinoid THC, and MS patients who suffer from muscle spasticity can be prescribed GW Pharmaceuticals' Sativex, a spray formulation of THC. Soon, many more patients who suffer from a variety of otherwise... Read more
25d
FOX Business
3 Things You Need To Know About This Marijuana Stock's First Quarter PerformanceSOURCE: GW PHARMACEUTICALS After updating investors on its first-quarter finan
3 Things You Need To Know About This Marijuana Stock's First Quarter Performance
FOX Business / Posted 25 days ago
SOURCE: GW PHARMACEUTICALS After updating investors on its first-quarter financials,investors may be wondering if marijuana drug developer GW Pharmaceuticals' shares should be bought or sold. Here are 3 key takeaways from GW Pharmaceuticals report... Read more
3 related stories
25d
FOX Business
3 Things You Need To Know About This Marijuana Stock's First Quarter PerformanceSOURCE: GW PHARMACEUTICALS Continue Reading Below After updating investors on
3 Things You Need To Know About This Marijuana Stock's First Quarter Performance
FOX Business / Posted 25 days ago
SOURCE: GW PHARMACEUTICALS Continue Reading Below After updating investors on its first-quarter financials,investors may be wondering if marijuana drug developer GW Pharmaceuticals' shares should be bought or sold. Here are 3 key takeaways from GW... Read more
3 related stories
27d
TheStreet.com
Marijuana companies evolving and scaling to list on Nasdaq, attract investorsand now it's under $1,” he said. A handful of companies with proven track reco
Marijuana companies evolving and scaling to list on Nasdaq, attract investors
TheStreet.com / Posted 27 days ago
and now it's under $1,” he said. A handful of companies with proven track records are listed on the Nasdaq, including GW Pharmaceuticals (GWPH), a U.K.–based biotech company with a cannabis-based epilepsy drug, Insys Therapeutics (INSY - Get... Read more
28d
TheStreet.com
These 5 stocks are set to soar on bullish earnings this weekGW Pharmaceuticals My first earnings short-squeeze play is biopharmaceutical p
These 5 stocks are set to soar on bullish earnings this week
TheStreet.com / Posted 28 days ago
GW Pharmaceuticals My first earnings short-squeeze play is biopharmaceutical player GW Pharmaceuticals (GWPH) , which is set to release numbers on Thursday before the market open. Wall Street analysts, on average, expect GW Pharmaceutical to report... Read more
6 related stories

People in this news